 |
|
Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients With Coronary Artery Disease
The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) Trial
François Lespérance, MD;
Nancy Frasure-Smith, PhD;
Diana Koszycki, PhD;
Marc-André Laliberté, MD;
Louis T. van Zyl, MD;
Brian Baker, MBChB;
John Robert Swenson, MD;
Kayhan Ghatavi, MD;
Beth L. Abramson, MD;
Paul Dorian, MD;
Marie-Claude Guertin, PhD; for the CREATE Investigators
JAMA. 2007;297:367-379.
Context Few randomized controlled trials have evaluated the efficacy of treatments for major depression in patients with coronary artery disease (CAD). None have simultaneously evaluated an antidepressant and short-term psychotherapy.
Objective To document the short-term efficacy of a selective serotonin reuptake inhibitor (citalopram) and interpersonal psychotherapy (IPT) in reducing depressive symptoms in patients with CAD and major depression.
Design, Setting, and Participants The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy, a randomized, controlled, 12-week, parallel-group, 2 x 2 factorial trial conducted May 1, 2002, to March 20, 2006, among 284 patients with CAD from 9 Canadian academic centers. All patients met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for diagnosis of major depression of 4 weeks' duration or longer and had baseline 24-item Hamilton Depression Rating Scale (HAM-D) scores of 20 or higher.
Interventions Participants underwent 2 separate randomizations: (1) to receive 12 weekly sessions of IPT plus clinical management (n = 142) or clinical management only (n = 142) and (2) to receive 12 weeks of citalopram, 20 to 40 mg/d (n = 142), or matching placebo (n = 142).
Main Outcome Measures The primary outcome measure was change between baseline and 12 weeks on the 24-item HAM-D, administered blindly during centralized telephone interviews (tested at  = .033); the secondary outcome measure was self-reported Beck Depression Inventory II (BDI-II) score (tested at = .017).
Results Citalopram was superior to placebo in reducing 12-week HAM-D scores (mean difference, 3.3 points; 96.7% confidence interval [CI], 0.80-5.85; P = .005), with a small to medium effect size of 0.33. Mean HAM-D response (52.8% vs 40.1%; P = .03) and remission rates (35.9% vs 22.5%; P = .01) and the reduction in BDI-II scores (difference, 3.6 points; 98.3% CI, 0.58-6.64; P = .005; effect size = 0.33) also favored citalopram. There was no evidence of a benefit of IPT over clinical management, with the mean HAM-D difference favoring clinical management (–2.26 points; 96.7% CI, –4.78 to 0.27; P = .06; effect size, 0.23). The difference on the BDI-II did not favor clinical management (1.13 points; 98.3% CI, –1.90 to 4.16; P = .37; effect size = 0.11).
Conclusions This trial documents the efficacy of citalopram administered in conjunction with weekly clinical management for major depression among patients with CAD and found no evidence of added value of IPT over clinical management. Based on these results and those of previous trials, citalopram or sertraline plus clinical management should be considered as a first-step treatment for patients with CAD and major depression.
Trial Registration isrctn.org Identifier: ISRCTN15858091
Author Affiliations: Department of Psychiatry, Université de Montréal (Drs Lespérance, Frasure-Smith, and Laliberté), Research Centre, Centre Hospitalier de l’Université de Montréal (Drs Lespérance and Frasure-Smith), Research Centre (Drs Lespérance and Frasure-Smith), Department of Psychosomatic Medicine (Dr Laliberté), and Coordinating Centre (Dr Guertin), Montreal Heart Institute, and Department of Psychiatry and School of Nursing, McGill University (Dr Frasure-Smith), Montreal, Quebec; Department of Psychiatry, University of Ottawa (Drs Koszycki and Swenson), University of Ottawa Institute of Mental Health Research, Royal Ottawa Hospital (Dr Koszycki), University of Ottawa Heart Institute (Dr Swenson), and Department of Psychiatry of the Ottawa Hospital (Dr Swenson), Ottawa, Ontario; Department of Psychiatry, Queen's University and Kingston General Hospital Canada, Kingston, Ontario (Dr van Zyl); Department of Psychiatry, University Health Network and University of Toronto (Dr Baker), Department of Medicine, University of Toronto (Drs Abramson and Dorian), and Division of Cardiology (Drs Abramson and Dorian) and Cardiac Prevention Centre and Women's Cardiovascular Health (Dr Abramson), St Michael's Hospital, Toronto, Ontario; and Department of Psychiatry, Dalhousie University, Capital District Health Authority, Halifax, Nova Scotia (Dr Ghatavi).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
RELATED LETTERS
Treatment of Depression in Patients With Coronary Artery Disease
Roy C. Ziegelstein
JAMA. 2007;297(17):1878-1879.
EXTRACT
| FULL TEXT
Treatment of Depression in Patients With Coronary Artery Disease
Ellen A. Dornelas and Matthew M. Burg
JAMA. 2007;297(17):1879-1880.
EXTRACT
| FULL TEXT
Treatment of Depression in Patients With Coronary Artery Disease—Reply
François Lespérance and Nancy Frasure-Smith
JAMA. 2007;297(17):1880.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Antidepressants in Coronary Heart Disease: SSRIs Reduce Depression, But Do They Save Lives?
Alexander H. Glassman and J. Thomas Bigger, Jr
JAMA. 2007;297(4):411-412.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
The efficacy of psychological interventions for infertile patients: a meta-analysis examining mental health and pregnancy rate
Hammerli et al.
Hum Reprod Update 2009;15:279-295.
ABSTRACT
| FULL TEXT
Treatment-Resistant Depression and Mortality After Acute Coronary Syndrome
Carney and Freedland
Am. J. Psychiatry 2009;166:410-417.
ABSTRACT
| FULL TEXT
History of Depression and Survival After Acute Myocardial Infarction
Carney et al.
Psychosom. Med. 2009;71:253-259.
ABSTRACT
| FULL TEXT
The Bypassing the Blues Treatment Protocol: Stepped Collaborative Care for Treating Post-CABG Depression
Rollman et al.
Psychosom. Med. 2009;71:217-230.
ABSTRACT
| FULL TEXT
Depression and heart disease: What do we know, and where are we headed?
POZUELO et al.
Cleveland Clinic Journal of Medicine 2009;76:59-70.
ABSTRACT
| FULL TEXT
AAFP Guideline for the Detection and Management of Post-Myocardial Infarction Depression
Post-Myocardial Infarction Depression Clinical Pra
Ann Fam Med 2009;7:71-79.
FULL TEXT
Impact of Depression on Sex Differences in Outcome After Myocardial Infarction
Parashar et al.
Circ Cardiovasc Qual Outcomes 2009;2:33-40.
ABSTRACT
| FULL TEXT
Depression Screening and Patient Outcomes in Cardiovascular Care: A Systematic Review
Thombs et al.
JAMA 2008;300:2161-2171.
ABSTRACT
| FULL TEXT
Antidepressant Use, Depression, and Survival in Patients With Heart Failure
O'Connor et al.
Arch Intern Med 2008;168:2232-2237.
ABSTRACT
| FULL TEXT
Depression and Coronary Heart Disease: Recommendations for Screening, Referral, and Treatment: A Science Advisory From the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Psychiatric Association
Lichtman et al.
Circulation 2008;118:1768-1775.
ABSTRACT
| FULL TEXT
Pre-Existing Major Depression Predicts In-Hospital Cardiac Complications After Acute Myocardial Infarction
Huffman et al.
Psychosomatics 2008;49:309-316.
ABSTRACT
| FULL TEXT
Heterogeneity of Patients With Coronary Artery Disease and Distress and the Need to Identify Relevant Subtypes
de Jonge and Ormel
Arch Gen Psychiatry 2008;65:851-852.
FULL TEXT
Heterogeneity of Patients With Coronary Artery Disease and Distress and the Need to Identify Relevant Subtypes--Reply
Frasure-Smith and Lesperance
Arch Gen Psychiatry 2008;65:852-853.
FULL TEXT
Case 14-2008 -- A 78-Year-Old Man with Anergia and Anhedonia Associated with Cardiovascular Surgery
Huffman et al.
NEJM 2008;358:2051-2059.
FULL TEXT
Remission From Depression Comorbid With Chronic Illness and Physical Impairment
Turvey and Klein
Am. J. Psychiatry 2008;165:569-574.
FULL TEXT
Depression in Patients With Heart Failure: Prevalence, Pathophysiological Mechanisms, and Treatment
Thomas et al.
Crit Care Nurse 2008;28:40-55.
FULL TEXT
Depression, antidepressants and heart disease
DTB 2008;46:29-32.
ABSTRACT
| FULL TEXT
Effect of Selective Serotonin Reuptake Inhibitors on Cardiovascular Morbidity and Mortality
Von Ruden et al.
J CARDIOVASC PHARMACOL THER 2008;13:32-40.
ABSTRACT
Pre-existent depression in the 2 weeks before an acute coronary syndrome can be associated with delayed presentation of the heart attack
Wong et al.
QJM 2008;101:137-144.
ABSTRACT
| FULL TEXT
Major Depressive Disorder
Belmaker and Agam
NEJM 2008;358:55-68.
FULL TEXT
Bibliography for Major Depressive Disorder and Suicide
Focus 2008;6:58-62.
FULL TEXT
Depression and Anxiety as Predictors of 2-Year Cardiac Events in Patients With Stable Coronary Artery Disease
Frasure-Smith and Lesperance
Arch Gen Psychiatry 2008;65:62-71.
ABSTRACT
| FULL TEXT
Rationale and design of a randomised, controlled, multicenter trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF)
Angermann et al.
Eur J Heart Fail 2007;9:1212-1222.
ABSTRACT
| FULL TEXT
Depression, Inflammation, and Incident Cardiovascular Disease in Women With Suspected Coronary Ischemia: The National Heart, Lung, and Blood Institute Sponsored WISE Study
Vaccarino et al.
J Am Coll Cardiol 2007;50:2044-2050.
ABSTRACT
| FULL TEXT
Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study rationale, design, and methodological issues
Blumenthal et al.
Clin Trials 2007;4:548-559.
ABSTRACT
Treatment of Post-Myocardial Infarction Depressive Disorder: A Randomized, Placebo-Controlled Trial With Mirtazapine
Honig et al.
Psychosom. Med. 2007;69:606-613.
ABSTRACT
| FULL TEXT
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
Anderson et al.
J Am Coll Cardiol 2007;50:e1-e157.
FULL TEXT
Citalopram, but not interpersonal psychotherapy, improves major depression in people with coronary artery disease
Parashar and Rumsfeld
Evid. Based Ment. Health 2007;10:80-80.
FULL TEXT
Additional articles abstracted in ACP Journal Club
Evid. Based Med. 2007;12:94-94.
FULL TEXT
Treatment of Depression in Patients With Coronary Artery Disease
Dornelas and Burg
JAMA 2007;297:1879-1880.
FULL TEXT
Treatment of Depression in Patients With Coronary Artery Disease
Ziegelstein
JAMA 2007;297:1878-1879.
FULL TEXT
Et al
Evid. Based Ment. Health 2007;10:39-40.
FULL TEXT
SSRIs and Medical Illness: The Good and the Bad
JWatch Psychiatry 2007;2007:1-1.
FULL TEXT
Citalopram lifts depression after heart disease
BMJ 2007;334:230-230.
FULL TEXT
Antidepressants in Coronary Heart Disease: SSRIs Reduce Depression, But Do They Save Lives?
Glassman and Bigger
JAMA 2007;297:411-412.
FULL TEXT
SSRIs in Patients with Heart Disease
JWatch General 2007;2007:1-1.
FULL TEXT
|
